TAMPA, Fla. — Discussion of advancements in cancer treatment, patient care improvement, and fundraising strategies is on the agenda at Moffitt Cancer Center’s 14th annual Business of Biotech Conference: Setting the Pace in the Cancer Race. The event brings together research organizations, entrepreneurs and investors, biomedical companies and startups each year, as well as collaborations, partnership and networking opportunities. This year, the conference takes place Friday, Feb. 7, from 8:30 a.m. to 3 p.m. in Moffitt’s Vincent A. Stabile Research Building.
“Business of Biotech is an impactful and memorable conference that has advanced to become one of Florida’s most opportunistic and top gatherings for the biotech community,” said Latanya Scott, conference co-chair with Industry Alliances at Moffitt. “Since its launch in 2006, each conference has served as an opportunity to create partnerships and to learn from one another about various technological advancements that can lead to life-changing futures.”
This year’s interview-style keynote features Alice Jacobs, M.D., who is recognized as a physician, entrepreneur, inventor and investor. Jacobs not only successfully brought multiple products through the Food and Drug Administration and onto five continents during her time at Harvard Medical School, but also developed a further understanding of the cerebral cortex through her independent research in neuroscience. She holds numerous patents and has been recognized by Scientific American as one of the top 50 innovators and by the World Economic Forum as a Young Global Leader.
“We are excited to have Dr. Jacobs as this year’s keynote address speaker,” said Scott. “Her foundational achievements and their unlimited potential to change the world for good are an inspiration for all who are seeking growth in their research and experience.”
In addition to Jacob’s appearance, the conference will also include four informative breakout sessions and tours of Moffitt’s hospital and research facilities.
About Moffitt Cancer Center
Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 51 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt is a Top 10 cancer hospital and has been nationally ranked by U.S. News & World Report since 1999. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 6,500 team members, Moffitt has an economic impact in the state of $2.4 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter, Instagram and YouTube.